M1FG
ADMA icon

Mach-1 Financial Group’s ADMA Biologics ADMA Stock Holding History

Mach-1 Financial Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,562
Closed -$329K – 217
2025
Q1 		$329K Buy
+16,562
New +$286K 0.1% 171

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Mach-1 Financial Group's ADMA Position: Q2 2025 in Review

Mach-1 Financial Group sold out of ADMA Biologics (ADMA) in Q2 2025, closing a stake of 16,562 shares — an estimated $329K sold.

Mach-1 Financial Group first reported a position in ADMA in Q1 2025 and held it in 1 quarter. The position peaked at $329K in Q1 2025. 368 funds tracked by Wall St. Rank hold ADMA as of Q2 2025.

  • Mach-1 Financial Group reported no remaining ADMA Biologics position as of Q2 2025 after selling out during the quarter.
  • Mach-1 Financial Group sold 16,562 ADMA Biologics shares in Q2 2025, an estimated $329K.
  • Mach-1 Financial Group first reported a position in ADMA Biologics in Q1 2025 and held it in 1 quarter.
  • Mach-1 Financial Group's ADMA Biologics position peaked at $329K in Q1 2025.
  • 368 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2025.

Based on Mach-1 Financial Group's 13F filing for Q2 2025, filed 11 Aug 2025.